ArticleESC heart failure2018

Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al.

Felix J A Ramires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.